Summarized quarterly data for fiscal years 2015 and 2014 follows:



	Quarter Ended
	September 30(a)			December 31(a)			March 31(a)			June 30			Year Ended(a)
	(Dollars in thousands, except per share amounts)
2015
Revenues	$	464,551		$	455,887		$	453,960		$	462,889		$	1,837,287
Cost of service and product revenues, excluding depreciation and amortization	268,664			268,049			261,947			264,615			1,063,275
Operating (loss) income	(754		)	(671		)	5,402			(446		)	3,531
Loss from continuing operations(c)	(9,843		)	(16,663		)	(4,763		)	(1,943		)	(33,212		)
Loss from discontinued operations(d)	—			—			—			(630		)	(630		)
Net loss(c)(d)	(9,843		)	(16,663		)	(4,763		)	(2,573		)	(33,842		)
Loss from continuing operations per share, basic and diluted(e)	(0.18		)	(0.30		)	(0.09		)	(0.04		)	(0.60		)
Loss from discontinued operations per share, basic and diluted	—			—			—			(0.01		)	(0.01		)
Net loss per basic and diluted share(e)	(0.18		)	(0.30		)	(0.09		)	(0.05		)	(0.62		)



	Quarter Ended
	September 30(a)			December 31(a)			March 31(a)			June 30(a)			Year Ended(a)
	(Dollars in thousands, except per share amounts)
2014
Revenues	$	468,583		$	468,367		$	471,561		$	483,926		$	1,892,437
Cost of service and product revenues, excluding depreciation and amortization	268,759			273,874			272,490			279,095			1,094,218
Operating income (loss)(b)	35			(34,233		)	(3,218		)	2,458			(34,958		)
Loss from continuing operations(b)(c)	(1,153		)	(110,889		)	(10,090		)	(17,742		)	(139,874		)
Income from discontinued operations(d)	—			—			609			744			1,353
Net loss(b)(c)(d)	(1,153		)	(110,889		)	(9,481		)	(16,998		)	(138,521		)
Loss from continuing operations per share, basic and diluted(e)	(0.02		)	(1.96		)	(0.18		)	(0.31		)	(2.48		)
Income from discontinued operations per share, basic and diluted	—			—			0.01			0.01			0.02
Net loss per basic and diluted share(e)	(0.02		)	(1.96		)	(0.17		)	(0.30		)	(2.45		)
Dividends declared per share	0.06			0.06			—			—			0.12

_______________________________________________________________________________

(a)

Amounts for fiscal years 2015 and 2014 have been revised from what was previously filed. As a result of this revision, net loss as previously presented for the three months ended September 30, 2014, December 31, 2014 and March 31, 2015 increased (decreased) by $0.8, $(2.4) and $1.1 million, respectively. Net loss as previously presented for the three months ended September 30, 2013, December 31, 2013, March 31, 2014 and June 30, 2014 increased by $1.0, $1.8, $0 and $0 million, respectively. The Company plans to reflect the revised amounts in its quarterly Condensed Consolidated Financial Statements for fiscal 2015 in future filings containing such information. See Note 1 to the Consolidated Financial Statements.


(b)	During the second quarter of fiscal year 2014, the Company recorded a goodwill impairment charge of $34.9 million and a $4.7 million non-cash salon asset impairment charge. During the third quarter of fiscal 2014, the Company recorded non-cash salon impairment of $8.9 million.

(c)

During the second quarter of fiscal year 2015, the Company recorded a $4.7 million other than temporary impairment charge and $6.9 million of its share of the of a deferred tax valuation allowance on its investment in EEG. During the fourth quarter of fiscal year 2014, the Company recorded a $12.6 million charge representing its share of goodwill impairment charges recorded by EEG. During the second quarter of fiscal year 2014, the Company recorded an $86.6 million non-cash charge to establish a valuation allowance against the Company’s U.S. and U.K. deferred tax assets.


(d)	During the fourth quarter of fiscal year 2015, the Company recorded expenses of $0.6 million in discontinued operations related to legal fees related to Trade Secret. During fiscal year 2014, the Company recorded tax benefits of $1.4 million in discontinued operations related to the release of tax reserves associated with the disposition of Trade Secret.


(e)	Total is an annual recalculation; line items calculated quarterly may not sum to total.